Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTNK-tPA in Acute Non-large Vessel Occlusion Ischemic Stroke (OPTION)
NCT05752916Phase 4Completed
- Sponsor
- Xuanwu Hospital
- Start
- Jun 2023
- Primary completion
- Oct 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tenecteplase in ischemic stroke, sponsored by Xuanwu Hospital. Started Jun 2023; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05752916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05752916.